Am J Transplant, Volume 18, Suppl 3 Archives - Page 37 of 211 - ATC Abstracts

2018 American Transplant Congress
Improved Value with Individualized Antithymocyte Globulin Dosing Protocol in Renal Transplant
J. Dann, W. Ally, M. Bradley, J. Geyston, A. Agarwal.
University of Virginia Healthsystem, Charlottesville, VA.
Medication costs represent one of the largest costs associated with transplantation. With growing pressure to reduce health care costs while maintaining excellent outcomes, this study…
2018 American Transplant Congress
Long Term Outcomes of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant
Y. Kassis,¹ S. Park,¹ A. Shetty,¹ J. Leventhal,¹ V. Mas,² L. Gallon.¹
¹Comprehensive Transplant Center, Northwestern University, Chicago, IL; ²Department of Surgery, University of Virginia, Charlottesville, VA.
Tacrolimus (Tac) is the most effective immunosuppressive agent to prevent acute allograft rejection. However, long-term transplant (Tx) outcomes are limited, at least in part, by…
2018 American Transplant Congress
A Novel Protocol to Improve Kidney Transplant Outcomes in Patients with Renal Disease Due to Amyloidosis
A. Langone, B. Concepcion, D. Slosky, R. Cornell, S. Horst, S. Goodman.
Vanderbilt University Medical Center, Nashville, TN.
In 2011, members from 10 different medical disciplines formed the Vanderbilt Amyloid Multidisciplinary Program (VAMP) in an effort to improve regional recognition of this rare…
2018 American Transplant Congress
Positive Implications of an Enhanced Recovery after Surgery Protocol Using Liposomal Bupivacaine for Transverse Abdominis Plane Block in the Perioperative Phase of Robotic Assisted Laparoscopic Living Donor Nephrectomy
A. Nickkholgh,¹ A. Agarwal,¹ B. Sarosiek,² A. Sites,³ A. Nishio Lucar,⁴ J. Oberholzer,¹ P. Amato.⁵
¹Dept. of Surgery, University of Virginia Health System, Charlottesville, VA; ²ERAS Program, University of Virginia Health System, Charlottesville, VA; ³Strickler Transplant Institute, University of Virginia Health System, Charlottesville, VA; ⁴Dept. of Internal Medicine, University of Virginia Health System, Charlottesville, VA; ⁵Dept. of Anesthesiology, University of Virginia Health System, Charlottesville, VA.
Introduction. Enhanced Recovery After Surgery (ERAS) protocols aim to mitigate the physical and psychological stress response to surgery. Postop pain can increase the need for…
2018 American Transplant Congress
Attitudes of African Canadian Patients with End Stage Kidney Disease toward Living Donor Kidney Transplantation
V. Gupta, C. Richardson, D. Belenko, N. Singh, A. Xu, P. Thiagalingam, D. Wong, H. Ford, M. Novak, I. Mucsi.
University Health Network, Toronto, ON, Canada.
Background:African Canadian patients with end stage kidney disease (ESKD) are less likely to receive a living donor kidney transplant (LDKT) compared to Caucasian Canadians. We…
2018 American Transplant Congress
An Initial Experience with the Endowrist Robotic Endostapling Device for Renal Donor Nephrectomy
M. Tan, H. Pollinger.
Piedmont Transplant Institute, Atlanta.
Introduction:Robot assisted donor nephrectomy has been used an advancement to standard laparoscopic techniques. However, limitations in available instrumentation reduce the efficiency of the procedure especially…
2018 American Transplant Congress
Involvement of Additional Surgeons in Robot Assisted Kidney Transplantation Does Not Affect Surgical Outcomes, in the Context of a Structured Robotic Surgery Program. Results from a CUSUM Analysis
F. Gheza,¹ C. Di Bella,¹ P. Giulianotti,¹ J. Oberholzer,² E. Benedetti,¹ I. Tzvetanov.¹
¹Surgery, University of Illinois, Chicago, IL; ²Surgery, University of Virginia, Virginia, VA.
Robot assisted kidney transplant (RAKT) is a good option for obese recipients. Our group first performed this procedure in 2009 and nowadays the experience includes…
2018 American Transplant Congress
Role of BK Virus-Specific T Cell Immune Monitoring for BK Virus-Associated Nephropathy in Kidney Transplant Recipients
J. Bruminhent,¹ S. Srisala,² C. Klinmalai,³ S. Pinsai,¹ S. Watcharananan,¹ S. Kantachuvessiri,⁵ S. Hongeng,⁴ N. Apiwattanakul.³
¹Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; ²Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; ³Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; ⁴Division of Hematology and Oncology, Department of Pediatrics Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; ⁵Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Background: Reduced immunosuppression in a key therapy for BK virus (BKV)-associated nephropathy (BKVAN) in kidney transplant (KT) recipients. A study of immune monitoring against BKV…
2018 American Transplant Congress
The Impact of Conversion from Immediate Release Twice-Daily Tacrolimus (Prograf®) to Once-Daily Extended Release Tacrolimus (Envarsus®) in Liver Transplant Recipients
M. Del Gaudio,¹ M. Cescon,¹ M. Ravaioli,¹ V. Bertuzzo,¹ C. Zanfi,¹ M. Serenari,¹ L. Maroni,¹ C. Morelli,² A. Pinna.¹
¹Organ Insufficiency and Transplantation, S.Orsola Hospital General Surgery and Transplantation Unit Prof. A.D. Pinna, Bologna, Italy; ²Organ Insufficiency and Transplantation, S. Orsola Hospital Organ Insufficiency and Internal Medicine Morelli, Bologna, Italy.
The safety and efficacy of substitution with a novel once-daily extended-release tacrolimus (LCPT;Envarsus®)to immediate-release tacrolimus (IR-Tac, Prograf®) twice daily in liver transplant patients have not…
2018 American Transplant Congress
Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients
M. Selim,¹ M. Zimmerman,¹ J. Kim,¹ T. Pearson,¹ C. Eriksen,¹ M. Wong,¹ B. Boettcher,² K. Regner,³ K. Saeian,⁴ H. Woehlk,² J. Hong.¹
¹Department of Surgery, Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI; ²Department of Anesthesia, Medical College of Wisconsin, Milwaukee, WI; ³Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI; ⁴Department of Medicine, Division of Gastroenterology, Medical College of Wisconsin, Milwaukee, WI.
Objective: Liver transplantation (LT) is a lifesaving treatment for end stage liver disease (ESLD). High acuity ESLD patients are disadvantaged as they are frequently denied…